Clinical Trial Update: Liposomal Amphotericin B Plus Posaconazole/Isavuconazole for Mucormycosis in Hematologic Malignancies: Efficacy and Safety

View source ↗

Summary

A clinical trial is evaluating the efficacy and safety of a combination therapy of liposomal amphotericin B with posaconazole or isavuconazole for mucormycosis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucormycosis

Drugs mentioned

• Isavuconazole (Isavuconazole)
• Liposomal amphotericin B (amphotericin B liposomal)
• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Mucormycosis in Hematologic Malignancies | Status: RECRUITING